Recent Publications
Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Dietzen DJ, Langefeld CD, Freedman BI.
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab. 2013;98(1):E60-E65.
Divers J, Palmer ND, Lu L, Register TC, Carr JJ, Hicks PJ, Hightower RC, Smith SC, Xu J, Cox AJ, Hruska KA, Bowden DW, Lewis CE, Heiss G, Province MA, Borecki IB, Kerr KF, Chen YD, Palmas W, Rotter JI, Wassel CL, Bertoni AG,.
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet. 2013;6(1):97-105.
Ng MCY, Hester JM, Wing MR, Li J, Xu J, Hicks PJ, Roh BH, Lu L, Divers J, Langefeld CD, Freedman BI, Palmer ND, Bowden DW.
Genome-wide association of BMI in African Americans. Obesity (Silver Spring). 2012;20(3):622-627.
Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN, Bostrom MA, Rudock ME, Talbert ME, Lewis JP, Lu L, Ziegler JT, Divers J, Ng MCY, Langefeld CD, Freedman BI, Bowden DW, et al.
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS ONE. 2012;7(1):e29202.
Manichaikul A, Palmas W, Rodriguez CJ, Peralta CA, Divers J, Guo X, Chen W-M, Wong Q, Williams K, Kerr KF, Taylor KD, Tsai MY, Goodarzi MO, Sale MM, Diez-Roux AV, Rich SS, Rotter JI, Mychaleckyj JC.
Population structure of Hispanics in the United States: the Multi-Ethnic Study of Atherosclerosis. PLoS Genet. 2012;8(4):e1002640.
Freedman BI, Langefeld CD, Turner J, Nunez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J.
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012;82(7):805-811.
Murea M, Register TC, Divers J, Bowden DW, Carr JJ, Hightower CR, Xu J, Smith SC, Hruska KA, Langefeld CD, Freedman BI.
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study. BMC Nephrol. 2012;13(1):148.
Ramos PS, Sajuthi S, Huang Y, Kamen DL, Divers J, Kaufman KM, Harley JB, Kimberly RP, Langefeld CD, Sale MM, Garvey WT, Gilkeson GS. Genes associated with systemic lupus erythematosus show evidence of selection in the Gullah African American population [abstract]. Arthritis Rheum. 2012;64(10 Suppl):S962.
Freedman BI, Murea M, Rocco MV, Ma L, Bowden DW, Ornelles DA, Kleiboeker S, Langefeld CD, Turner J, Divers J. JC polyoma virus interacts with apolipoprotein L1 genetic risk in African Americans with non-diabetic nephropathy [abstract]. J Am Soc Nephrol. 2012;23():178A.
McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MCY, Divers J, Langefeld CD, Freedman BI, Bowden DW, et al.
A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int. 2011;79(5):563-572.
Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI.
The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.
Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW, et al.
Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans. PLoS Genet. 2011;7(6):e1002150.
Pasaniuc B, Zaitlen N, Lettre G, Chen GK, Tandon A, Kao WHL, Ruczinski I, Fornage M, Siscovick DS, Divers J, et al.
Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet. 2011;7(4):e1001371.
Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KAB, Langefeld CD, Hanson RL, Duggirala R, Divers J, Bowden DW, Freedman BI, et al.
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol. 2011;33(5):381-389.
Bhatia G, Patterson N, Pasaniuc B, Zaitlen N, Genovese G, Pollack S, Mallick S, Myers S, Tandon A, Divers J, et al.
Genome-wide comparison of African-ancestry populations from CARe and other cohorts reveals signals of natural selection. Am J Hum Genet. 2011;89(3):368-381.
Murea M, Register TC, Divers J, Bowden DW, Carr JJ, Hightower RC, Smith SC, Hruska KA, Langefeld CD, Freedman BI. Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):715A.
Freedman BI, Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW. Sickle cell trait is not associated with ESRD susceptibility in African Americans [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):463A.
Ng MCY, Sajuthi S, Cupples A, Divers J, Dupuis J, Fornage M, Kao L, Larkin E, Freedman B, Bowden DW, et al. Genetic ancestry and population structure of geographically separated African American populations [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada). 2011;():.
Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS.
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant. 2011;26(11):3805-3810.
Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J.
Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab. 2010;95(3):1076-1083.
Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarcon GS, Brown EE, McGwin G Jr, Langefeld CD, et al.
The non-muscle myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol. 2010;32(1):66-72.
Harley ITW, Niewold TB, Stormont RM, Kaufman KM, Glenn SB, Franek BS, Kelly JA, Kilpatrick JR, Divers J, Langefeld CD, et al.
The role of genetic variation near interferon-kappa in systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010():706825.
Mcdonough CW, Allred ND, Hicks PJ, Bostrom MA, Lu L, Ng M, Divers J, Langefeld CD, Freedman BI, Bowden DW. A genome wide association study for diabetic nephropathy genes in African Americans [abstract]. J Am Soc Nephrol. 2010;21(Suppl):729A.
Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Allred ND, Hicks PJ, Bostrom MA, Cooke JN, Mcdonough CW, Bowden DW, et al. Accounting for risk variants in MYH9 reveals FRMD3 association with diabetic ESRD in African Americans [abstract]. J Am Soc Nephrol. 2010;21(Suppl):728A.
Murea M, Lu L, Hicks PJ, Bowden DW, Divers J, Langefeld CD, Freedman BI. Genetic variants identified by GWAS suggest intracellular calcium, vascular remodeling, and cardiac repolarization pathways impact dialytic survival in African Americans with diabetes [abstract]. J Am Soc Nephrol. 2010;21(Suppl):730A.
Cooke JN, Bostrom MA, Hicks PJ, Ng M, Comeau ME, Divers J, Langefeld CD, Freedman BI, Bowden DW. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans [abstract]. J Am Soc Nephrol. 2010;21(Suppl):731A.
Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, Eckfeldt JH, Leppert MF, Hicks PJ, Divers J, Langefeld CD, Hunt SC.
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Am J Nephrol. 2009;29(6):626-632.
Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al.
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 2009;75(7):736-745.
Guo L, Deshmukh H, Lu R, Vidal GS, Kelly JA, Kaufman KM, Langefeld CD, Marion MC, Williams AH, Divers J, et al.
Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Genes Immun. 2009;10(5):531-538.
Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez N, Langefeld CD, Marion MC, Divers J, et al.
Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 2009;10(5):397-403.
Namjou B, Gray-McGuire C, Sestak AL, Gilkeson GS, Jacob CO, Merrill JT, James JA, Langefeld CD, Divers J, Ziegler J, et al.
Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 2009;10(5):517-524.
Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al.
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant. 2009;24(11):3366-3371.
Divers J, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Xu J, Langefeld CD, Freedman BI. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: African American-Diabetes Heart Study [abstract]. J Am Soc Nephrol. 2009;20(Renal Week 2009 Abstract Issue):395A.
McDonough CW, Palmer ND, Bostrom MA, Hicks PJ, Lu L, Divers J, Langefeld CD, Freedman BI, Bowden DW. A genome-wide association study (GWAS) of diabetic nephropathy (DN) in African Americans (AA) [abstract]. J Am Soc Nephrol. 2009;20(Renal Week 2009 Abstract Issue):433A.
Freedman BI, Bostrom MA, Cooke JN, Divers J, Langefeld CD, Nelson RG, Kretzler M, Maeda S, Bowden DW. ACACB gene associations with type 2 diabetes-associated ESRD [abstract]. J Am Soc Nephrol. 2009;20(Renal Week 2009 Abstract Issue):55A.
Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans (AA) with type 2 diabetes (T2DM)-associated ESRD [abstract]. J Am Soc Nephrol. 2009;20(Renal Week 2009 Abstract Issue):431A.
Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Divers J, Freedman BI, et al.
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40(10):1185-1192.
Bowden DW, Lewis JP, Allred ND, Langefeld CD, Divers J, Freedman BI. Genetic analysis of 'European' type 2 diabetes SNPs from whole genome association studies in African Americans [abstract]. Diabetologia. 2008;51(Suppl 1):S129.
Kao L, Klag M, Meoni L, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Divers J, Freedman B, et al. Admixture scan identifies MYH9 locus to be associated with non-diabetic ESRD in African Americans [abstract]. J Am Soc Nephrol. 2008;19():58A.
Freedman BI, Hicks PJ, Bostrom MA, Divers J, Winkler CA, Kopp JB, Nelson GW, Cunningham ME, Langefeld CD, Bowden DW. Non-muscle myosin heavy chain 9 (MYH9) gene associations in African Americans (AA) with non-diabetic ESRD [abstract]. J Am Soc Nephrol. 2008;19():132A.
Freedman BI, Edberg C, Kopp JB, Winkler CA, Nelson GW, Alarcon GS, Brown EE, Divers J, Cunningham ME, Langefeld CD, et al. Association analysis of the non-muscle myosin heavy chain 9 (MYH9) gene in African Americans with lupus nephritis (LN) [abstract]. J Am Soc Nephrol. 2008;19():134A.
Divers J, Vaughan LK, Padilla M, Fernandez JR, Allison DB, Redden DT. Correcting for measurement error in individual ancestry estimates in structured association tests [abstract]. Genet Epidemiol. 2007;31(6):624.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.